Go to JCI Insight
Jci spelled out white on transparent.20160208
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Cellular senescence in human disease (Apr 2018)
    • Fibrosis (Jan 2018)
    • Glia and Neurodegeneration (Sep 2017)
    • Transplantation (Jun 2017)
    • Nuclear Receptors (Apr 2017)
    • Metabolism and Inflammation (Jan 2017)
    • Hypoxia and Inflammation (Oct 2016)
    • View all review series...
  • Collections
    • Recently published
    • Commentaries
    • Concise Communication
    • Editorials
    • Opinion
    • Scientific Show Stoppers
    • Top read articles
    • In-Press Preview
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

Jci only white

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication

JCI Editorial Board
First-tier potential conflicts of interest

 

AbbVie Pharmaceuticals (T.M. Dawson)

Aeras (M.L. Reitman)

Alliance for Lupus (M.J. Kaplan)

American Gene Technologies International (T.M. Dawson)

Amgen (D.A. Kass)

Ardelyx (M. Donowitz)

Biogen (P.A. Calabresi)

BluebirdBio (J.D. Powell)

Boehringer Ingelheim (D.A. Kass)

CHD Bioscience (W. Nelson)

Commonwealth Foundation (M.Y. Armanios)

Corvus (J.D. Powell)

Digital Harmonic (W. Nelson)

Emulate (M. Donowitz)

Gemstone Biotherapeutics (S. Gerecht)

Genentech (S. Desiderio)

Gilead (T.C. Quinn)

Inhibikase (T.M. Dawson)

Intra-Cellular Therapies (D.A. Kass)

Ionis Pharmaceuticals (C. Sumner)

Janssen (A.M. DeMarzo)

Johnson & Johnson (A.P. Feinberg)

Loxo Oncology (B.H. Park)

MedImmune (P.A. Calabresi)

Merck (M. Donowitz)

miDiagnostics (S.C. Ray)

MycoMed Technologies (K.A. Marr)

Myriad Genetics (A.M. DeMarzo)

Navitor Pharmaceuticals (J.D. Powell)

Neuraly (T.M. Dawson)

NexImmune (J. Schneck)

Novartis (P.A. Calabresi)

Pfizer (D.A. Kass, W. Nelson)

ProQuest Investments (W. Nelson)

Sanofi (J.D. Powell)

SPARC (T.M. Dawson)

Teva Pharmaceutical Industries Ltd. (P.A. Calabresi, W. Nelson)

Thermo Fisher (A.P. Feinberg)

Titan Pharmaceuticals (W.R. Bishai)

Advertisement
Follow JCI: Facebook logo white Twitter logo v2 Rss icon
Copyright © 2018 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts